PKS Holdings Ltd (pks) Logo

PKS Holdings Ltd (PKS)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

PKS Chart

Snapshot

PKS's Principal Activity is the provision of software services to the healthcare industry.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) +117.37%
vs ASX 200 (1yr) +99.08%

Size

Market Capitalisation
ASX Rank 967 of 2,319
Sector Rank 84 of 198

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies LGP / AHX / MXC
EPS $0.002
DPS $0.00
NTA per share $0.02

Broker Consensus

PKS is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

PKS Holdings Limited (PKS) is a healthcare technology company which provides a proprietary subscription based Clinical Decision Support (CDS) system called "RippleDown". RippleDown automates the human decision-making process in healthcare organisations and has two components that address a number of the key issues faced by healthcare organisations: RippleDown Auditor and RippleDown Expert. PKS Holdings Limited is based in Sydney, Australia.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Redfern NSW 2016
Website www.pks.com.au
Registry Automic Group
Auditor HLB Mann Judd Assurance (NSW) Pty Ltd
Date Listed 6 Jun 2019

Upcoming Calendar (Forecasted)

Date Event
27/08/2021 Report (Prelim)
27/08/2021 Report (Annual)
22/02/2022 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Ms Belinda Ann Cleminson Company Secretary Apr 2021
Mr Jim Birch Non-Executive Director Mar 2021 Director Bio icon

Mr Jim Birch

Non-Executive Director

Mr Birch has more than 30 years' experience in implementing technological change in the healthcare industry, having previously served as Chair of the Australian Digital Health Agency, Deputy Chair of the Independent Hospital Pricing Authority, CEO of the SA Department of Health, and global healthcare leader for consulting firm EY. He is currently Chair of the Little Company of Mary Health Care (Calvary), the Australian Red Cross Blood Service (now known as Lifeblood), the SA Women's and Children's Health Network and Clevertar Pty Ltd.

Mr Timothy Kelsey Chief Executive Officer Oct 2020
Mr Stephen Frederick Borness Non-Executive Director Jun 2020 Director Bio icon

Mr Stephen Frederick Borness

Non-Executive Director

Mr Borness has founded and directed strategy for several technology and health related private companies, and was Board Chair and Finance Director of Pavilion Health before it merged with PKS. He has led projects and has expertise in im-plementation of digital technologies, health system analytics and cybersecurity. Prior to focusing on the health and technology sectors Mr Borness worked as an investment banker across the Australian, European and U.S. markets.

Mr Brad Lancken Non-Executive Director Oct 2019 Director Bio icon

Mr Brad Lancken

Non-Executive Director

Mr Lancken is an experienced private and public company executive with over 15 years experience and is a Managing Partner of Liverpool Partners with former roles at Archer Capital and Seven Group Holdings Limited. Brad has global experience in the technology and SaaS sector including former roles on the advisory board of China Media Capital Partners and as a Board Director of Onesource Group. iseekplant.com.au and Found Careers. He also has domestic health care experience having led investments in the aged care sector, currently a Director of residential aged care provider CraigCare and serves the community as a Director of the NSW Institute of Sport.

Mr Paul Williams Non-Executive Director May 2019 Director Bio icon

Mr Paul Williams

Non-Executive Director

Mr Williams has a proven history of ICT managerial performance across the health, transport, logistics and resources industries, most recently as Chief Information Officer at Healthscope Ltd where he was responsible for all ICT activities at Australia's largest provider of integrated healthcare, covering 44 private hospitals across Australia, national and international pathology services and 50 medical centres. He has experience in delivering innovation, change and reform within large and complex businesses. Prior to Healthscope, Paul was the Head of Information Services at the National E-Health Transition Authority and National IT Manager, Pathology for Mayne/Symbion/Primary. He is chairperson of Risk Committee.

Mr Andrew Gray Non-Executive Director May 2019 Director Bio icon

Mr Andrew Gray

Non-Executive Director

Mr Gray is a Managing Director of Potentia, a technology-focused private equity investment firm. Before founding Potentia, Andrew was a Managing Director at Archer Capital, an Australian based private equity firm with more than $3 billion in capital under management. While at Archer Capital, Andrew led the firm's largest investment into software business MYOB (its largest ever return to inves-tors). Before joining Archer Capital, Andrew was a partner with Francisco Partners, a technology-focused global private equity firm with over US$10 billion in capital under management. Andrew serves as Chairman of Ascender HCM, a leading payroll software provider and Chairman of Linkly, a provider of payments integra-tion software. He is also a Director of Micromine, a general mine planning soft-ware business, PKS, a listed healthcare software business. He was former Non-Executive Director of LiveTiles Limited.

Mr Michael (Mike) Hastings Hill Non-Executive Chairman,Non-Executive Director Jun 2018 Director Bio icon

Mr Michael (Mike) Hastings Hill

Non-Executive Chairman,Non-Executive Director

Mr Hill was Partner of Ernst & Young, Mike has been involved in working with management teams and boards across a number of companies and industries for more than 20 years. He is the MD, Co-CIO and Founder of the Bombora Special Investments Fund. Prior to Bombora he was an Investment Partner with Ironbridge, a private equity investment fund which invested $1.5bn. Mike has served as Chairman of multiple ASX-listed companies over the past six years. Other current directorships includes AHAlife Holdings Limited (Non-Executive Chairman) and Janison Education Group Limited (Chairman). Former directorships includes Rhipe Limited (Non-Executive Chairman) resigned on 26 March 2019, LiveTiles Limited (Non-Executive Director) resigned on 5 September 2017, JustKapital Litigation Partners Limited (Non-Executive Director) resigned on 27 November 2017, Acrow Formwork and Construction Limited (Non-Executive Director) resigned on 19 43709

Director Transactions

PKS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
23/04/21 Stephen Borness Issued 1,342,857 $0.35 $469,999 Issue of securities
23/04/21 Andrew Gray Issued 5,000,000 $0.35 $1,750,000 Issue of securities
04/09/20 Stephen Borness Buy +250,000 $0.25 $62,500 On-market trade
10/06/20 Brad Lancken Issued 1,000,000 $0.175 $175,000 Director remuneration
10/06/20 Brad Lancken Issued 375,000 $0.175 $65,625 Director remuneration
20/05/20 Michael (Mike) Hill Buy +117,000 $0.17 $19,890 On-market trade

Director Interests

The current holdings of PKS directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Andrew Gray 25/06/2021 100,000 7,000,000 0 N/A
Stephen Borness 23/04/2021 N/A 11,297,984 N/A N/A
Jim Birch 17/03/2021 0 N/A N/A N/A
Brad Lancken 30/06/2020 N/A 1,000,000 375,000 N/A
Michael (Mike) Hill 30/06/2020 N/A 1,367,000 N/A N/A
Paul Williams 30/06/2020 250,000 N/A 150,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 21, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Celerity Investments Pty Limited 9,455,127 5.07%
Paul Richard O'Connor 9,330,331 5.01%
Paul Richard O'Connor i 9,330,330 5.01%
Freestate Holdings Pty Ltd 8,948,312 4.80%
Freestate Holdings Pty Ltd i 8,948,312 4.80%
National Nominees Limited 7,235,000 3.88%
Mirrabooka Investments Limited 7,216,100 3.87%
Bombora Investment Management Pty Ltd 5,600,000 3.00%
Sandhurst Trustees Ltd 4,805,140 2.58%
Castlereagh Equity Pty Ltd 3,900,000 2.09%
Mohamed Hassan Khadra 3,456,275 1.85%
Ozren Tosic 3,273,150 1.76%
Stephen John Menzies 2,763,941 1.48%
Mr Christopher Bell 2,499,000 1.34%
Shorebrook Pty Ltd 2,201,903 1.18%
David Bambach 2,073,545 1.11%
Jamplat Pty Ltd 1,800,000 0.97%
Michael B Pollitt 1,789,774 0.96%
Michael B Pollitt i 1,789,773 0.96%
Mary Ethna Black 1,728,144 0.93%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Paul O'Connor 21/08/2020 9,330,331 5.01
Paul O'Connor 21/08/2020 9,330,330 5.01
Stephen Borness 23/04/2021 11,297,984 5.03
Mirrabooka Investments Limited 26/02/2021 9,673,818 5.16
Bombora Investment Management Pty Limited 26/02/2021 18,600,000 8.63

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
23-04-21 Stephen Borness 11,297,984 -- 5.03
26-02-21 Bombora Investment Management Pty Limited 6,015,000 10.39 8.63
26-02-21 Mirrabooka Investments Limited 9,673,818 -- 5.16

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
01-03-21 Celerity Investments Pty Limited 9,705,127 5.21 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $0.17 30 June
2019 $0.19 28 June
Page Icon
PKS Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.